Qualcomm Backs goBalto For Clinical Trials Software

San Diego-based Qualcomm Ventures, the venture capital arm of Qualcomm, has backed goBalto, a developer of clinical trial workflow software. goBalto said it raised $12M in a Series B funding, which was led by Singapore Economic Development Board, and which also included new investor Qualcomm Life Fund. Qualcomm Life Fund is the $100M health investment fund run by Qualcomm. Other investors in the round included Aberdare Ventures and West Health Investment Fund.